The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2019

Filed:

Sep. 13, 2017
Applicant:

University of Pittsburgh—of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Song Li, Wexford, PA (US);

Yixian Huang, Pittsburgh, PA (US);

Xiaolan Zhang, Foster City, CA (US);

Xiang Gao, Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/60 (2017.01); A61K 31/337 (2006.01); A61K 31/235 (2006.01); A61K 31/704 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); C08G 65/331 (2006.01); C08G 65/333 (2006.01); C08G 65/334 (2006.01);
U.S. Cl.
CPC ...
A61K 47/60 (2017.08); A61K 9/0019 (2013.01); A61K 9/1075 (2013.01); A61K 31/235 (2013.01); A61K 31/337 (2013.01); A61K 31/704 (2013.01); C08G 65/331 (2013.01); C08G 65/334 (2013.01); C08G 65/3311 (2013.01); C08G 65/3344 (2013.01); C08G 65/33306 (2013.01); C08G 65/33396 (2013.01); C08L 2203/02 (2013.01);
Abstract

A formulation includes a carrier agent formed by conjugating at least one biologically active hydrophobic compound with at least one hydrophilic compound, the at least one biologically active hydrophobic compound selected from the group of farnesylthiosalicylic acid and a derivative of farnesylthiosalicylic acid which is biologically active as an RAS antagonist, wherein a plurality of the carrier agents are adapted to assemble into a structure and the at least one biologically active hydrophobic compound is conjugated with the at least one hydrophilic compound via a linkage which is labile in vivo, and a biologically active compound associated with the carrier agent.


Find Patent Forward Citations

Loading…